Dr Reddy's Laboratories Total Current Assets 2010-2024 | RDY
Dr Reddy's Laboratories total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
- Dr Reddy's Laboratories total current assets for the quarter ending September 30, 2024 were $2.962B, a 13.05% increase year-over-year.
- Dr Reddy's Laboratories total current assets for 2024 were $2.976B, a 18.19% increase from 2023.
- Dr Reddy's Laboratories total current assets for 2023 were $2.518B, a 5.05% increase from 2022.
- Dr Reddy's Laboratories total current assets for 2022 were $2.397B, a 18.25% increase from 2021.
Dr Reddy's Laboratories Annual Total Current Assets
(Millions of US $) |
| 2024 |
$2,976 |
| 2023 |
$2,518 |
| 2022 |
$2,397 |
| 2021 |
$2,027 |
| 2020 |
$1,729 |
| 2019 |
$1,656 |
| 2018 |
$1,684 |
| 2017 |
$1,548 |
| 2016 |
$1,807 |
| 2015 |
$1,923 |
| 2014 |
$1,729 |
| 2013 |
$1,572 |
| 2012 |
$1,375 |
| 2011 |
$1,069 |
| 2010 |
$936 |
| 2009 |
$99 |
Dr Reddy's Laboratories Quarterly Total Current Assets
(Millions of US $) |
| 2024-09-30 |
$2,962 |
| 2024-06-30 |
$3,230 |
| 2024-03-31 |
$2,976 |
| 2023-12-31 |
$2,867 |
| 2023-09-30 |
$2,620 |
| 2023-06-30 |
$2,562 |
| 2023-03-31 |
$2,518 |
| 2022-12-31 |
$2,351 |
| 2022-09-30 |
$2,158 |
| 2022-06-30 |
$2,274 |
| 2022-03-31 |
$2,397 |
| 2021-12-31 |
$2,243 |
| 2021-09-30 |
$2,204 |
| 2021-06-30 |
$2,136 |
| 2021-03-31 |
$2,027 |
| 2020-12-31 |
$1,827 |
| 2020-09-30 |
$1,836 |
| 2020-06-30 |
$1,760 |
| 2020-03-31 |
$1,729 |
| 2019-12-31 |
$1,643 |
| 2019-09-30 |
$1,700 |
| 2019-06-30 |
$1,677 |
| 2019-03-31 |
$1,656 |
| 2018-12-31 |
$1,623 |
| 2018-09-30 |
$1,594 |
| 2018-06-30 |
$1,678 |
| 2018-03-31 |
$1,684 |
| 2017-12-31 |
$1,715 |
| 2017-09-30 |
$1,577 |
| 2017-06-30 |
$1,548 |
| 2017-03-31 |
$1,548 |
| 2016-12-31 |
$1,551 |
| 2016-09-30 |
$1,504 |
| 2016-06-30 |
$1,511 |
| 2016-03-31 |
$1,807 |
| 2015-12-31 |
$1,803 |
| 2015-09-30 |
$1,774 |
| 2015-06-30 |
$1,823 |
| 2015-03-31 |
$1,923 |
| 2014-12-31 |
$1,772 |
| 2014-09-30 |
$1,734 |
| 2014-06-30 |
$1,762 |
| 2014-03-31 |
$1,729 |
| 2013-12-31 |
$1,645 |
| 2013-09-30 |
$1,553 |
| 2013-06-30 |
$1,541 |
| 2013-03-31 |
$1,572 |
| 2012-12-31 |
$1,535 |
| 2012-09-30 |
$1,490 |
| 2012-06-30 |
$1,344 |
| 2012-03-31 |
$1,375 |
| 2011-12-31 |
$1,356 |
| 2011-09-30 |
$1,160 |
| 2011-06-30 |
$1,088 |
| 2011-03-31 |
$1,069 |
| 2010-12-31 |
$920 |
| 2010-09-30 |
$908 |
| 2010-06-30 |
$915 |
| 2010-03-31 |
$936 |
| 2009-12-31 |
$804 |
| 2009-09-30 |
$781 |
| 2009-06-30 |
$824 |
| 2009-03-31 |
$766 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$11.677B |
$3.350B |
|
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.
|
